0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27H11910
Home | Market Reports | Health| Aging & Geriatrics
Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Alzheimer's Disease Drug Market Research Report 2025

Code: QYRE-Auto-27H11910
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Alzheimer's Disease Drug Market Size

The global market for Alzheimer's Disease Drug was valued at US$ 3727 million in the year 2024 and is projected to reach a revised size of US$ 4130 million by 2031, growing at a CAGR of 1.5% during the forecast period.

Alzheimer's Disease Drug Market

Alzheimer's Disease Drug Market

Alzheimer"s disease (AD), also referred to simply as Alzheimer"s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alzheimer's Disease Drug Market Report

Report Metric Details
Report Name Alzheimer's Disease Drug Market
Accounted market size in year US$ 3727 million
Forecasted market size in 2031 US$ 4130 million
CAGR 1.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Donepezil
  • Memantine
  • Rivastigmine
  • Others
Segment by Application
  • Early to Moderate Stages
  • Moderate to Severe Stages
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Alzheimer's Disease Drug Market growing?

Ans: The Alzheimer's Disease Drug Market witnessing a CAGR of 1.5% during the forecast period 2025-2031.

What is the Alzheimer's Disease Drug Market size in 2031?

Ans: The Alzheimer's Disease Drug Market size in 2031 will be US$ 4130 million.

What is the market share of major companies in Alzheimer's Disease Drug Market?

Ans: The top 3 players hold over 60% of global shares.

What is the Alzheimer's Disease Drug Market share by type?

Ans: Memantine and Donepezil are the main types, with a share about 70%.

What is the Alzheimer's Disease Drug Market share by application?

Ans: Early to Moderate Stages is the key application, which covers over 55% shares.

Who are the main players in the Alzheimer's Disease Drug Market report?

Ans: The main players in the Alzheimer's Disease Drug Market are Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Applications covered in the Alzheimer's Disease Drug Market report are Early to Moderate Stages, Moderate to Severe Stages

What are the Type segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Types covered in the Alzheimer's Disease Drug Market report are Donepezil, Memantine, Rivastigmine, Others

1 Alzheimer's Disease Drug Market Overview
1.1 Product Definition
1.2 Alzheimer's Disease Drug by Type
1.2.1 Global Alzheimer's Disease Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Alzheimer's Disease Drug by Application
1.3.1 Global Alzheimer's Disease Drug Market Value by Application (2024 VS 2031)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease Drug Revenue 2020-2031
1.4.2 Global Alzheimer's Disease Drug Sales 2020-2031
1.4.3 Global Alzheimer's Disease Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alzheimer's Disease Drug Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alzheimer's Disease Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
2.7 Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry
2.8 Global Alzheimer's Disease Drug Market Competitive Situation and Trends
2.8.1 Global Alzheimer's Disease Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alzheimer's Disease Drug Players Market Share by Revenue
2.8.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alzheimer's Disease Drug Market Scenario by Region
3.1 Global Alzheimer's Disease Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alzheimer's Disease Drug Sales by Region: 2020-2031
3.2.1 Global Alzheimer's Disease Drug Sales by Region: 2020-2025
3.2.2 Global Alzheimer's Disease Drug Sales by Region: 2026-2031
3.3 Global Alzheimer's Disease Drug Revenue by Region: 2020-2031
3.3.1 Global Alzheimer's Disease Drug Revenue by Region: 2020-2025
3.3.2 Global Alzheimer's Disease Drug Revenue by Region: 2026-2031
3.4 North America Alzheimer's Disease Drug Market Facts & Figures by Country
3.4.1 North America Alzheimer's Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alzheimer's Disease Drug Sales by Country (2020-2031)
3.4.3 North America Alzheimer's Disease Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
3.5.1 Europe Alzheimer's Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alzheimer's Disease Drug Sales by Country (2020-2031)
3.5.3 Europe Alzheimer's Disease Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Alzheimer's Disease Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alzheimer's Disease Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Alzheimer's Disease Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
3.7.1 Latin America Alzheimer's Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alzheimer's Disease Drug Sales by Country (2020-2031)
3.7.3 Latin America Alzheimer's Disease Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alzheimer's Disease Drug Sales by Type (2020-2031)
4.1.1 Global Alzheimer's Disease Drug Sales by Type (2020-2025)
4.1.2 Global Alzheimer's Disease Drug Sales by Type (2026-2031)
4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2020-2031)
4.2 Global Alzheimer's Disease Drug Revenue by Type (2020-2031)
4.2.1 Global Alzheimer's Disease Drug Revenue by Type (2020-2025)
4.2.2 Global Alzheimer's Disease Drug Revenue by Type (2026-2031)
4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2020-2031)
4.3 Global Alzheimer's Disease Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alzheimer's Disease Drug Sales by Application (2020-2031)
5.1.1 Global Alzheimer's Disease Drug Sales by Application (2020-2025)
5.1.2 Global Alzheimer's Disease Drug Sales by Application (2026-2031)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2020-2031)
5.2 Global Alzheimer's Disease Drug Revenue by Application (2020-2031)
5.2.1 Global Alzheimer's Disease Drug Revenue by Application (2020-2025)
5.2.2 Global Alzheimer's Disease Drug Revenue by Application (2026-2031)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2020-2031)
5.3 Global Alzheimer's Disease Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Company Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Company Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Merz Pharma
6.5.1 Merz Pharma Company Information
6.5.2 Merz Pharma Description and Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
6.5.5 Merz Pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.7.1 Johnson & Johnson Company Information
6.7.2 Johnson & Johnson Description and Business Overview
6.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Company Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alzheimer's Disease Drug Industry Chain Analysis
7.2 Alzheimer's Disease Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alzheimer's Disease Drug Production Mode & Process Analysis
7.4 Alzheimer's Disease Drug Sales and Marketing
7.4.1 Alzheimer's Disease Drug Sales Channels
7.4.2 Alzheimer's Disease Drug Distributors
7.5 Alzheimer's Disease Drug Customer Analysis
8 Alzheimer's Disease Drug Market Dynamics
8.1 Alzheimer's Disease Drug Industry Trends
8.2 Alzheimer's Disease Drug Market Drivers
8.3 Alzheimer's Disease Drug Market Challenges
8.4 Alzheimer's Disease Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Alzheimer's Disease Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alzheimer's Disease Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alzheimer's Disease Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alzheimer's Disease Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alzheimer's Disease Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alzheimer's Disease Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alzheimer's Disease Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Alzheimer's Disease Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Alzheimer's Disease Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Alzheimer's Disease Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alzheimer's Disease Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Alzheimer's Disease Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alzheimer's Disease Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Alzheimer's Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alzheimer's Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alzheimer's Disease Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alzheimer's Disease Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Alzheimer's Disease Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alzheimer's Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alzheimer's Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alzheimer's Disease Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Alzheimer's Disease Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Alzheimer's Disease Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alzheimer's Disease Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Alzheimer's Disease Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Alzheimer's Disease Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Alzheimer's Disease Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Alzheimer's Disease Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alzheimer's Disease Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Alzheimer's Disease Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Alzheimer's Disease Drug Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Eisai Company Information
 Table 76. Eisai Description and Business Overview
 Table 77. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eisai Alzheimer's Disease Drug Product
 Table 79. Eisai Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Alzheimer's Disease Drug Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Daiichi Sankyo Company Information
 Table 86. Daiichi Sankyo Description and Business Overview
 Table 87. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Daiichi Sankyo Alzheimer's Disease Drug Product
 Table 89. Daiichi Sankyo Recent Developments/Updates
 Table 90. Merz Pharma Company Information
 Table 91. Merz Pharma Description and Business Overview
 Table 92. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merz Pharma Alzheimer's Disease Drug Product
 Table 94. Merz Pharma Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Alzheimer's Disease Drug Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Johnson & Johnson Company Information
 Table 101. Johnson & Johnson Description and Business Overview
 Table 102. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Johnson & Johnson Alzheimer's Disease Drug Product
 Table 104. Johnson & Johnson Recent Developments/Updates
 Table 105. Lundbeck Company Information
 Table 106. Lundbeck Description and Business Overview
 Table 107. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Lundbeck Alzheimer's Disease Drug Product
 Table 109. Lundbeck Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Alzheimer's Disease Drug Distributors List
 Table 113. Alzheimer's Disease Drug Customers List
 Table 114. Alzheimer's Disease Drug Market Trends
 Table 115. Alzheimer's Disease Drug Market Drivers
 Table 116. Alzheimer's Disease Drug Market Challenges
 Table 117. Alzheimer's Disease Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alzheimer's Disease Drug
 Figure 2. Global Alzheimer's Disease Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alzheimer's Disease Drug Market Share by Type: 2024 & 2031
 Figure 4. Donepezil Product Picture
 Figure 5. Memantine Product Picture
 Figure 6. Rivastigmine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Alzheimer's Disease Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Alzheimer's Disease Drug Market Share by Application: 2024 & 2031
 Figure 10. Early to Moderate Stages
 Figure 11. Moderate to Severe Stages
 Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Alzheimer's Disease Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Alzheimer's Disease Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Alzheimer's Disease Drug Average Price (USD/Unit) & (2020-2031)
 Figure 16. Alzheimer's Disease Drug Report Years Considered
 Figure 17. Alzheimer's Disease Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Alzheimer's Disease Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Alzheimer's Disease Drug Players: Market Share by Revenue in Alzheimer's Disease Drug in 2024
 Figure 20. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Alzheimer's Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Alzheimer's Disease Drug by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Alzheimer's Disease Drug by Type (2020-2031)
 Figure 57. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Alzheimer's Disease Drug by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Alzheimer's Disease Drug by Application (2020-2031)
 Figure 60. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2020-2031)
 Figure 61. Alzheimer's Disease Drug Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS